To test whether angiotensinogen might be targeted to dense core secretory granules in cells containing a regulated secretory pathway, we expressed rat angiotensinogen in AtT-20 cells, a mouse pituitary cell line that has the demonstrated ability to correctly sort proteins to the constitutive or regulated pathway. We compared the pattern of secretion of angiotensinogen with that of endogenous adrenocorticotropin hormone, which is secreted by AtT-20 cells through the regulated pathway. When cells were incubated for 5 hours with dibutyryladenosine cyclic monophosphate or KCI, adrenocorticotropin hormone secretion was significantly higher than control, whereas monensin had no effect In contrast, angiotensinogen secretion was markedly reduced by monensin, but no stimulation was observed with dibutyryladenosine cyclic monophosphate or KCI. These results make it unlikely that angiotensinogen could be cotargeted with active renin in the dense core granules of the regulated pathway. Alternative mechanisms must explain how angiotensin II is synthesized locally by tissue renin-angiotensin systems. (Hypertension 1990;16:147-153)
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Alternative mechanisms must explain how angiotensin II is synthesized locally by tissue renin-angiotensin systems. (Hypertension 1990;16:147-153)
A ngiotensinogen plays a key role in blood pressure regulation, as it is the precursor to angiotensin II (Ang II), a potent vasoconstrictor and regulator of salt balance. The limiting step in the production of circulating Ang II appears to be the cleavage of hepatic angiotensinogen by renin, whose predominant source is the juxtaglomerular cells of the kidney. The released decapeptide angiotensin I (Ang I) is subsequently processed by angiotensin converting enzyme to release the bioactive octapeptide, Ang II.
Renin and angiotensinogen messenger RNAs (mRNA) have also been identified in a number of other tissues including the adrenal gland, the reproductive tissues, the anterior pituitary gland, and the brain.
1 " 6 The colocalization of Ang II in these tissues 7 - 10 has led to the proposal of tissue reninangiotensin systems whose role might be to produce Ang II for local action (for review, see References 11 and 12). However, the precise mechanisms governing the local generation of Ang II in tissues have not been fully explored, and there is still some debate whether Ang II is synthesized intracellularly or extracellularly.
12
' 13 In the kidney 14 - 15 and mouse submaxillary gland, 16 renin is secreted in two forms: the inactive prorenin, which is targeted to vesicles and secreted constitutively, and active renin, which is released in a regulated manner in response to secretagogues. The latter phenomenon has been explained by the diversion of a portion of prorenin to dense core secretory granules where it is processed to active renin by cleavage of the prosegment of the molecule 17 - 18 and stored for later release in response to a stimulus. By contrast, angiotensinogen appears to be secreted only constitutively (i.e., via vesicles) by the liver, This raises the question of how a cell packaging angiotensinogen in vesicles and renin in dense core secretory granules could assemble both components within a single subcellular compartment to produce angiotensin.
To test whether angiotensinogen could be targeted to dense core secretory granules in cells containing a regulated secretory pathway, we expressed rat angiotensinogen in AtT-20 cells, a mouse pituitary cell line that has the demonstrated ability to correctly sort proteins to the constitutive or regulated pathway, irrespective of tissue and species origin.
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- 28 Then we compared the pattern of secretion of angiotensinogen with that of endogenous adrenocorticotropin hormone (ACTH).
Methods

Recombinant Plasmid Construction
All plasmid constructions were carried out using standard recombinant DNA techniques as described in Maniatis et al. 29 The rat angiotensinogen complementary DNA (cDNA) was excised from the pRagl6 plasmid 30 by digestion with restriction enzymes Hindlll (cuts immediately upstream of the polylinker in the vector sequences) and Nco I (cuts between the termination codon and the polyadenylation signal). This fragment was then inserted in place of the 5' half of rabbit /3-globin in the expression vector pRSV-globin ( Figure 1 ; gift from Dr. Brian West, University of California at San Francisco). The resulting vector (pRSV-RAOG) contains the Rous sarcoma virus long terminal repeat (RSV-LTR) driving the expression of the rat angiotensinogen encoding cDNA. The RNA transcript contains the second intron and polyadenylation signal of the rabbit figlobin, although the protein translation product ends with the rat angiotensinogen termination codon. The untranslated globin fragment placed at the 3' end of the rat angiotensinogen encoding cDNA has the advantage of conferring increased stability to the corresponding mRNA when the plasmid is transcribed in mammalian cells. 31 
Maintenance and Transfection of Cell Cultures
Mouse pituitary AtT-20 cells were maintained in monolayer culture in Dulbecco's modified Eagle's medium (DMEM) H-21 supplemented with 10% fetal can 0 serum (FCS) and grown at 37° C in an atmosphere of 12% CO 2 and 88% air. Cells were replated 16 hours before transfection in 100 mm culture dishes (Falcon, Oxnard, Calif.) at approximately 50% confluence and were cotransfected with 30 fig pRSV-RAOG and 3 fig pSV2Neo ( contains neomycin-resistance gene sequences) by calcium phosphate coprecipitation. 32 After 24 hours, the culture medium was removed, the cells were shocked for 3 minutes with 15% grycerol in DMEM, washed twice with DMEM containing 10% FCS, and incubated for an additional 24 hours. The neomycin analogue G418 was then added to the growth medium at a concentration of 0.8 mg (by weight)/ml to select stable transfectants. After selection, the transfected cells (AtT-20-RAOG) were maintained in growth medium with G418 at a concentration of 0.2 mg/ml. G418 was omitted from the medium during the experimental incubations.
Rat hepatoma H4IEEC cells were maintained in DMEM containing 10% FCS at 37° C in an atmosphere of 6% CO 2 and 94% air.
Assays
Angiotensinogen concentration in all incubation medium was determined by incubating the samples with excess hog renin and measuring the generated Ang I by radioimmunoassay (RIA). Details of the procedure have been published previously.
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ACTH concentration in cell incubation medium was determined by RIA, using reagents provided as a kit (Incstar, Stilhvater, Minn.). The cross-reactivity of the ACTH antibody with other fragments of the proopiomelanocortin molecule was less than 0.01%. Total protein assays were performed according to the method of Bradford, 35 using reagents provided by Bio-Rad, Burlingame, Calif., and bovine thyroglobulin as a standard.
Ribonucleic Acid Preparation and Analysis
RNA was extracted from adult male rat livers or AtT-20-RAOG cells by disruption of the samples in a buffer containing 5 M guanidium monothiocyanate, 10% /3-mercaptoethanol, and 1% A^-lauroylsarcosine and by subsequent ultracentrifugation on a cushion of 5.7 M cesium chloride. Five micrograms liver RNA and 30 fig AtT-20 RNA were denatured with glyoxal and dimethylsulfoxide and size-fractionated on a 1.2% agarose gel according to the method of Thomas. 36 The position of the 18S and 28S ribosomal bands was determined by ultraviolet shadowing. The RNA was then blot-transferred to a nitrocellulose membrane, baked at 70° C, and hybridized to the phosphorus-32-labeled Ace I fragment of the pRagl6 rat angiotensinogen cDNA. 30 After washing, the blot was air dried and exposed to x-ray film.
Characterization of Secretion Products
Rat hepatoma H4IIEC cells and AtT-20-RAOG transfectants were allowed to grow to confluence in six-well plates. The culture medium was then rinsed twice with phosphate buffered saline (PBS) and replaced with 1 ml cysteine-free DMEM. After 1 hour of incubation at 37° C, 80 fid ^S-cysteine (specific activity 600 Ci/mmol; Amersham, Arlington Heights, 111.) was added to each well. The cells were rinsed two times with PBS, and incubated another 3 hours in 1 ml serum-free supplemented medium (see below). The medium was then collected, and nonspecific proteins were immunoprecipitated with normal rabbit serum and Protein A-Sepharose (Sigma Chemical Co., St. Louis, Mo.). Radiolabeled angiotensinogen was subsequently immunoprecipitated with the 0RN1 antirat angiotensinogen antiserum and Protein A-Sepharose. After separating the immunoprecipitated material from the beads by 5 minutes boiling, the labeled angiotensinogen was size-fractionated on a 10% denaturing polyacrylamide gel according to the method of Laemmli. 37 Rainbow protein molecular weight markers (Amersham) were run in parallel. The dried gel was exposed to an x-ray film and developed after 15 days exposure.
Secretion Experiments
AtT-20-RAOG cells were grown in six-well plates in DH21 containing 10% FCS. When they reached confluence, the wells were rinsed three times with PBS, and the medium was replaced with 1 ml serum-free supplemented medium (DH16-F12 containing 20 mM HEPES, 5 ^Ag/ml insulin, 5 /ug/ml transferrin, and 5 ng/ml selenium). The cells were incubated for various lengths of time, in the absence or presence of 10" 6 M monensin. The effect of two different secretagogues (60 mM KC1 and 1 mM dibutyryladenosine cyclic monophosphate) was tested. All the reagents described above were purchased from Sigma. At the end of the incubation, 10 /J was collected from each well for ACTH determination. The remaining incubation medium was dried under a stream of air and resuspended in 100 /il assay buffer for the angiotensinogen assay. The cells in each well were dissolved in 1 ml of \N NaOH for total protein content determination.
Statistics
Comparisons between groups were tested by oneway analysis of variance followed by a Newman-Keuls multiple comparison test.
Results
The angiotensinogen mRNA transcripts in the AtT-20-RAOG transfectants were characterized by Northern blot analysis. As expected from the fusion of angiotensinogen cDNA with /3-globin cDNA sequences, the majority of the transcripts were of higher molecular weight than angiotensinogen mRNA from rat liver (Figure 2) . A second minor band migrated slightly lower than the transcript from liver. Alternative splicing at the intron site in the /3-globin sequence may possibly account for this second transcript.
No angiotensinogen was detected in the incubation medium of nontransfected AtT-20 cells (data not shown). In contrast, the stable transfectants AtT-20-RAOG secreted assayable angiotensinogen in the medium. The amount of angiotensinogen detected in the medium after 20 hours incubation was approximately four times higher than what was detected after 5 hours incubation, indicating that the cells secreted angiotensinogen in a linear fashion over time (Figure 3) . The molecular weight of the angiotensinogen forms secreted by rat hepatoma H4IIEC cells and AtT-20-RAOG transfectants were compared by electrophoresis of the immunoprecipitated secretion products on a denaturing polyacrylamide gel. Five bands were detected from the medium of H4IIEC cells: a doublet at approximately 68 and 66 kDa, a band at 60 kDa, the strongest band at 56 kDa, and a very faint band at 47 kDa (Figure 4) , which is in agreement with previous reports of multiple glycosylation forms of angiotensinogen. 38 Both human 44 and mouse 45 renin have been shown to be targeted to the regulated secretory pathway in transfected AtT-20 cells. To determine whether rat angiotensinogen also contains such specific targeting sequences, we have transfected AtT-20 cells with a plasmid containing rat angiotensinogen cDNA whose expression is driven by a potent viral promoter. Stable transfectants containing the plasmid (AtT-20-RAOG) were selected and shown to express the angiotensinogen gene on three accounts: 1) they contained identifiable angiotensinogen mRNA transcripts, 2) they secreted protein products that could be immunoprecipitated by an antirat angiotensinogen antiserum, and 3) the secreted angiotensinogen was biologically active (i.e., it was cleavable by renin and generated Ang I). The molecular weight of the proteins secreted by the H4IIEC cells is in good agreement with an earlier study showing that the majority of the products secreted by rat hepatoma cells migrated between 56 and 60 kDa, and the molecular weight of unglycosylated angiotensinogen was approximately 48 kDa. 38 The heterogeneity of secreted angiotensinogen was fully accounted for by differences in glycosylation 38 and probably also accounts for the different pattern observed in AtT-20-RAOG cells. We have compared the characteristics of angiotensinogen secretion in AtT-20-RAOG cells to those of endogenous ACTH. We investigated the effects of two secretagogues: db-cAMP, which mimics the effects of a rise of intracellular cAMP, and KC1, which nonspecifically stimulates the release of secretory granules by general cell depolarization. We also investigated the effect of monensin. This monovalent ionophore blocks the transport of newly synthesized proteins out of the Golgi apparatus by neutralizing the acidic environment of secretory vesicles and has been shown to impair the constitutive secretory pathway.
18S-
-39
The characteristics of ACTH secretion were, as expected, those of the regulated pathway. Both dbcAMP and KC1 triggered ACTH secretion when the cells were incubated for 5 hours in the presence of the secretagogues. When the secretagogues were added for the shorter 2-hour period after an 18-hour incubation, a similar effect was observed. On the other hand, monensin had no effect on basal ACTH secretion during a 5-hour incubation, and only slightly reduced ACTH over a 20-hour incubation period. This is compatible with the characteristics of regulated secretory cells; because they store large amounts of secretory products, their capacity of acute release may remain unaffected when the synthesis or incorporation of newly synthesized proteins are blocked. 28 In contrast, the pattern of secretion of angiotensinogen was very different. Monensin profoundly decreased angiotensinogen secretion to 44% of control levels, after either 5 or 20 hours incubation. Neither db-cAMP or KC1 were capable of triggering a release of angiotensinogen. On the contrary, angiotensinogen secretion was reduced when the cells were incubated for 5 hours in the presence of KC1. One possible explanation is that perturbations of the intracellular Na + -K + balance have also been shown to selectively impair the constitutive secretory pathway. 39 Alternatively, it is possible that sustained depolarization interferes with new protein synthesis.
Given the clear dissociation in the patterns of secretion of ACTH and angiotensinogen, it is unlikely that angiotensinogen could be packaged in the dense core secretory granules of the regulated pathway. This is in good agreement with previous studies examining the subcellular distribution of angiotensinogen in tissues: in rat adrenal glands, angiotensinogen was found to be in a different compartment than in the renincontaining vesicular fraction 46 ; in dog brain, angiotensinogen was found in the soluble but not in the granular subcellular fraction. 47 In addition, most cells where expression of the angiotensinogen gene has been demonstrated unequivocally, including hepatocytes, 1 27 lack dense core secretory granules.
If angiotensinogen and active processed renin are not cocompartmentalized in dense core secretory granules, alternative mechanisms must explain how Ang II is synthesized locally by tissue renin-angiotensin systems. In fact, there is evidence that angiotensinogen and renin are produced by different cells in many tissues where the existence of local reninangiotensin systems has been postulated. In brain, angiotensinogen is made by astrocytes, 25 " 27 and Ang II has been localized in neurons. 48 " 50 In the rat adrenal gland, renin and Ang II are found in the zona glomerulosa, 2 -10 whereas angiotensinogen mRNA has been localized in the capsule. 24 In the rat pituitary gland, renin and Ang II have been found in gonadotrophs, 2 -8 - 51 whereas angiotensinogen has been localized in cells that do not contain pituitary hormones. 52 In kidneys, renin and Ang II have been found in the juxtaglomerular cells, 53 and angiotensinogen has been localized in proximal tubules. 20 In the rat testes, renin has been found in Leydig cells, 2 -54 but there is no evidence for local angiotensinogen synthesis. 1 -3 Thus, it is possible that different cells within these tissues secrete renin and angiotensinogen in the interstitial fluid, where the local generation of angiotensins actually occurs. Such a mechanism of local synthesis of Ang II has actually been suggested for the rat adrenal glands 46 and the kidneys. 55 Recent findings by Morris 56 suggest a second possible mechanism. It was found that Triton WR-1339, a nonhemofytic detergent that binds to plasma proteins, is concentrated within renincontaining granules in the kidney. Extracellular angiotensinogen may therefore be internalized and enter renin-containing granules, where it could be further processed. Such a mechanism may partly explain why Ang II has been localized by electron microscopy in secretory granules in the kidney, 53 the brain, 50 and the pituitary gland 8 in cells that do not secrete angiotensinogen.
Nevertheless, several authors have reported that Ang II is made intracellularly and released by various cell lines, including some neuroblastomas, 57 bovine aortic endothelial cells, 58 and the MA10 murine Leydig tumor cell line. 59 If angiotensinogen is not sorted into dense core granules containing active processed renin, which mechanism could be responsible for the intracellular generation of Ang II? The possibility of transient activation of prorenin in other compartments than dense core secretory granules should be considered. It has recently been reported that prorenin is in constant equilibrium with a small percentage of unfolded uncleaved active renin. 60 This phenomenon has been demonstrated in vitro at pH 7.4 but is even more likely to occur in intracellular organelles where the pH is generally more acidic. 61 This may allow for cleavage of angiotensinogen at an earlier stage in secretion when it is present in the same compartments as prorenin (e.g., the endoplasmic reticulum or the cis and medial Golgi apparatus).
The AtT-20 cell line may be a useful model to investigate those possible alternative mechanisms. Future studies using AtT-20 cells cotransfected with prorenin and angiotensinogen should be helpful in determining whether Ang I can be formed intracellularly or extracellularly.
